Otomycosis: management challenges and outcomes in a resource poor country

Authors

  • Lucky Onotai University of Port Harcourt College of Medicine and Teaching Hospital
  • Adaobi Elizabeth Osuji Department of ENT University of Port Harcourt Teaching Hospital, Alakahia, PMB 6173, Port Harcourt

DOI:

https://doi.org/10.60787/tnhj.v16i4.260

Keywords:

Otomycosis, antifungal ear drops, aural toileting, humidity, fungal studies, resource poor country.

Abstract

Background: Otomycosis is one of the commonest causes of otitis externa seen in otorhinolaryngology clinics especially in tropical regions of the world. This study determines the prevalence of otomycosis in Port Harcourt, Nigeria and highlights its management challenges and outcomes.

Patients and Methods: This is a retrospective study of patients seen in the Ear, Nose, and Throat clinics of the University of Port Harcourt Teaching Hospital, within a period of 5 years (from January 2009 to December 2013) who were diagnosed clinically with Otomycosis. Data extracted include; demographic data (age and sex), clinical features, predisposing factors, treatment and management outcomes. Data were illustrated using simple statistical tables and figures.

 Results: Our study revealed that out of 7486 patients seen in our clinics, 1115 were diagnosed clinically with Otomycosis, indicating a prevalence of 14.9%. Out of this, males were 553 (49.6%) and females 562 (50.4%) with M: F ratio of 1:1.02. The commonest 1108 (99.4%) symptom was itching in the ears followed by otalgia 998 (89.5%).The commonest 1113 (%) otoscopic finding was whitish debris in the external auditory canal.

The commonest 560 (50.22%) treatment modality used was ear syringing with warm normal saline + wick packing with antifungal cream + the use of antifungal ear drop (figure 2).

Conclusion: Clinical diagnosis of otomycosis and uninterrupted medical treatment with antifungal agents for 6 weeks after appropriate ear toileting can give good clinical outcomes despite the absence of facilities for laboratory diagnosis.

Downloads

Download data is not yet available.

Author Biographies

Lucky Onotai, University of Port Harcourt College of Medicine and Teaching Hospital

Dr. Onotai Lucky O. (JP),  MBBS, MSc (UK)-Healthcare Policy & Management (international), FWACS, FICS, Member AAOHNS-F, Associate Professor/Reader & Consultant ENT/Head and Neck Surgeon, University of Port-Harcourt/University of Port-Harcourt Teaching Hospital, Port Harcourt, Nigeria.

Adaobi Elizabeth Osuji, Department of ENT University of Port Harcourt Teaching Hospital, Alakahia, PMB 6173, Port Harcourt

Department of ENT University of Port Harcourt Teaching Hospital, Alakahia, PMB 6173, Port Harcourt

References

Nazeer HA, Mohiddin SK, Pakanati SS. Mycology of otomycosis in a Tertiary care Teaching Hospital.. J Res Med Den Sci. 2015; 3(1): 27-30.

Chander J, Maini S, Subrahmanyan S, Handa A Otomycosis--a clinico-mycological study and efficacy of mercurochrome in its treatment. Mycopathologia. 1996; 135(1):9-12.

Abdelazeem M., Gamea A., Mubarak H., Elzawawy N; Epidemiology, Causative agents, and Risk Factors Affecting Human Otomycosis Infections. Turk J Med Sci. 2015; 45(4): 620-6.

Fasunla J, Ibekwe T, Onakoya P. Otomycosis in Western Nigeria. Mycoses. 2008;51(1): 67–70.

Panchal P., Pethani J., Patel D., Rathal S., Shah P; Analysis of Various Fungal Agents in Clinically Suspected Cases of Otomycosis. Indian Journal of Basic and Applied Medical Research. 2013; 2(8): 865-869.

Mgbe R, Umana A, Adekanye A, Offiong M. Otomycosis - A Management Challenge in Calabar, South-South Nigeria. The internet Journal of Third World Medicine 2010, 9(2).

Satish HS., Viswanatha B., Manjuladevi M; A Clinical Study of Otomycosis. IOSR Journal of Dental and Medical Sciences. 2013; 5 (2): 57-62.

Gazzaz ZJ, Makhdom MN, Dhafar KO, Maimini O, Farooq MU, Rasheed A. Patterns of Otorhinolaryngological Disorders in Subjects with Diabetes. The International Medical Journal Malaysia. 2011; 10 (2):13-16

Pontes Z, Silva A, Lima E, Guerra M, Oliveira N. Otomycosis: a retrospective study. Braz J Otorhinolaryngol 2009; 75: 367–370.

Adoga AS and Iduh AA. Otomycosis in Jos Predisposing factors and management. Afr J Med Med Sci 2014. 43(1): 209-213

Farida Khan, Raza Muhammad, Muhammad Riaz Khan, FazalRehman, Johar Iqbal, Munib Khan, GoharUllah. Efficacy of topical clotrimazole in treatment of otomycosis. J Ayub Med Coll Abbottabad 2013; 25(1-2)

Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: Clinical features and Treatment Implications. Otolaryngol Head Neck Surg. 2006; 135 (5): 787-791.

Ashish K. Fungal spectrum in otomycosis patients. J Laryngol Otol 2005; 7: 30–35.

Nemati S, Hassanzadeh R, Khajeh Jahromi S, Delkhosh Nasrollah Abadi A. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol. 2014; 271(5):953-7.

Ologe FE, Nwabuisi C. Treatment outcome of otomycosis in Ilorin, Nigeria. West Afr J Med. 2002; 21(1):34–6.

Okoye BC, Onotai LO Pattern of geriatric otolaryngological diseases in Port Harcourt Niger J Med 2007; 16(3):239-4

Mgbor N, Gugnani HC. Otomycosis in Nigeria: treatment with mercurochrome. Mycoses.2001; 44(9–10):395–7

Gugnani HC, Okafor BC, Nzelibe F, Njoku-Obi AN. Etiological agents of otomycosis in Nigeria. Mycoses 1989; 32(5):224-9.

Downloads

Published

2017-02-28

How to Cite

Onotai, L., & Osuji, A. E. (2017). Otomycosis: management challenges and outcomes in a resource poor country. The Nigerian Health Journal, 16(4), 219. https://doi.org/10.60787/tnhj.v16i4.260
Abtract Views | PDF Download | EPUB Download: 895 / 520

Similar Articles

<< < 2 3 4 5 6 7 8 9 10 11 > >> 

You may also start an advanced similarity search for this article.